Search research articles
Contact Us
Filters
Showing results (81-90 of 188) with videos related to
Page
of 19
Sort By:
Genes & Development
|
June 17, 2018
JAK2 is dispensable for maintenance of JAK2 mutant B-cell acute lymphoblastic leukemias
Sang-Kyu Kim, Deborah A Knight, Lisa R Jones, et al.
Cancer Research
|
May 10, 2012
Radiotherapy increases the permissiveness of established mammary tumors to rejection by immunomodulatory antibodies
Inge Verbrugge, Jim Hagekyriakou, Leslie L Sharp, et al.
Cancer Research
|
December 3, 2015
The CDK9 Inhibitor Dinaciclib Exerts Potent Apoptotic and Antitumor Effects in Preclinical Models of MLL-Rearranged Acute Myeloid Leukemia
Adele Baker, Gareth P Gregory, Inge Verbrugge, et al.
Blood
|
December 9, 2008
Defining the target specificity of ABT-737 and synergistic antitumor activities in combination with histone deacetylase inhibitors
Kate F Whitecross, Amber E Alsop, Leonie A Cluse, et al.
Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research
|
March 29, 2008
The role of p202 in regulating hematopoietic cell proliferation and differentiation
Louise E Ludlow, Louise E Purton, Kim Klarmann, et al.
Leukemia & Lymphoma
|
August 26, 2016
Durable clinical remission induced by romidepsin for chemotherapy-refractory peripheral T-cell lymphoma with central nervous system involvement
Kah-Lok Chan, Carrie van der Weyden, Christine Khoo, et al.
International Journal of Radiation Oncology, Biology, Physics
|
May 23, 2021
Regulatory T Cells Shape the Differential Impact of Radiation Dose-Fractionation Schedules on Host Innate and Adaptive Antitumor Immune Defenses
Joseph Sia, Jim Hagekyriakou, Ioana Chindris, et al.
Plos One
|
February 18, 2009
Imprinted CDKN1C is a tumor suppressor in rhabdoid tumor and activated by restoration of SMARCB1 and histone deacetylase inhibitors
Elizabeth M Algar, Andrea Muscat, Vinod Dagar, et al.
Methods in Molecular Biology (Clifton, N.J.)
|
January 12, 2018
A Comprehensive Protocol Resource for Performing Pooled shRNA and CRISPR Screens
Leonie A Cluse, Iva Nikolic, Deborah Knight, et al.
The FEBS Journal
|
January 22, 2013
AKT signalling is required for ribosomal RNA synthesis and progression of Eμ-Myc B-cell lymphoma in vivo
Jennifer R Devlin, Katherine M Hannan, Pui Y Ng, et al.
Page
of 19
Search research articles
Search
Showing results (81-90 of 188) with videos related to
Sort By:
Page
of 19
Genes & Development
|
June 17, 2018
JAK2 is dispensable for maintenance of JAK2 mutant B-cell acute lymphoblastic leukemias
Sang-Kyu Kim, Deborah A Knight, Lisa R Jones, et al.
Cancer Research
|
May 10, 2012
Radiotherapy increases the permissiveness of established mammary tumors to rejection by immunomodulatory antibodies
Inge Verbrugge, Jim Hagekyriakou, Leslie L Sharp, et al.
Cancer Research
|
December 3, 2015
The CDK9 Inhibitor Dinaciclib Exerts Potent Apoptotic and Antitumor Effects in Preclinical Models of MLL-Rearranged Acute Myeloid Leukemia
Adele Baker, Gareth P Gregory, Inge Verbrugge, et al.
Blood
|
December 9, 2008
Defining the target specificity of ABT-737 and synergistic antitumor activities in combination with histone deacetylase inhibitors
Kate F Whitecross, Amber E Alsop, Leonie A Cluse, et al.
Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research
|
March 29, 2008
The role of p202 in regulating hematopoietic cell proliferation and differentiation
Louise E Ludlow, Louise E Purton, Kim Klarmann, et al.
Leukemia & Lymphoma
|
August 26, 2016
Durable clinical remission induced by romidepsin for chemotherapy-refractory peripheral T-cell lymphoma with central nervous system involvement
Kah-Lok Chan, Carrie van der Weyden, Christine Khoo, et al.
International Journal of Radiation Oncology, Biology, Physics
|
May 23, 2021
Regulatory T Cells Shape the Differential Impact of Radiation Dose-Fractionation Schedules on Host Innate and Adaptive Antitumor Immune Defenses
Joseph Sia, Jim Hagekyriakou, Ioana Chindris, et al.
Plos One
|
February 18, 2009
Imprinted CDKN1C is a tumor suppressor in rhabdoid tumor and activated by restoration of SMARCB1 and histone deacetylase inhibitors
Elizabeth M Algar, Andrea Muscat, Vinod Dagar, et al.
Methods in Molecular Biology (Clifton, N.J.)
|
January 12, 2018
A Comprehensive Protocol Resource for Performing Pooled shRNA and CRISPR Screens
Leonie A Cluse, Iva Nikolic, Deborah Knight, et al.
The FEBS Journal
|
January 22, 2013
AKT signalling is required for ribosomal RNA synthesis and progression of Eμ-Myc B-cell lymphoma in vivo
Jennifer R Devlin, Katherine M Hannan, Pui Y Ng, et al.
Page
of 19